Abstract:A 59-year-old woman was referred to our laryngology clinic for a 2-month history of fluctuating vocal quality and poor projection after a prodromal upper respiratory infection. Her initial vocal quality was severely breathy. It had partially improved, but she still complained of vocal fatigue and lack of vocal volume. Physical exam demonstrated no significant abnormalities aside from severe breathy dysphonia with a maximum phonation time of just 3 seconds and abnormal vocal fold motion. Videostroboscopy revealed sluggish adduction of the left vocal fold and arytenoid complex with a significant glottic gap throughout the phonatory cycle and decreased mucosal wave propagation. The patient was diagnosed with left true vocal fold paresis, and vocal fold augmentation was recommended to improve her glottic insufficiency. For topical nasal anesthesia, 4% lidocaine mixed equally with oxymetazoline was sprayed into the nasal cavity, and a total of 5 ml of 4% lidocaine was delivered directly to the endolarynx using the operative port on a flexible laryngoscope. Injection laryngoplasty was performed using a 23-gauge flexible sclerotherapy needle directed through the laryngoscope (figure, A). The paretic left vocal fold was augmented with 0.7 ml of hyaluronic acid delivered via a single posterior lateral injection (figure, B). The patient had immediate improvement in glottic closure with increased vocal strength and projection. Percutaneous or transoral vocal fold augmentation is a common in-office technique performed under local anesthesia, avoiding the high cost associated with direct laryngoscopy and general anesthesia in a hospital setting. Both approaches involve endoscopic imaging to visualize the injection site.1,2 Transnasal injection using a flexible needle via the operative port of a flexible laryngoscope allows for intraoperative assessment of vocal quality during injection laryngoplasty, with decreased gag reflex compared to transoral techniques.3 Transnasal vocal fold augmentation is tolerated well by patients, easy to perform, and can be done without an assistant. It allows for direct laryngeal delivery of numerous products including micronized Alloderm, hyaluronic acid, botulinum toxin, and steroid suspensions, among others.4 Viscous injection materials such as fat or calcium hydroxyapatite may be challenging to deliver using the 23-gauge flexible needle. Flexible laryngoscopy is a standard skill of the trained otolaryngologist, and injection by this technique is learned easily compared to more challenging percutaneous approaches.

More work is needed to explain why patients ask for amputation of healthy limbs

Artificial Intelligence-Driven Quantification of Antibiotic-Resistant Bacteria in Food by Color-Encoded Multiplex Hydrogel Digital LAMP

Detection of E-Coli O157:H7 Dna by A Novel Qcm Biosensor Coupled with Gold Nanoparticles Amplification

Rapid detection of Escherichia coli using bacteriophage-induced lysis and image analysis

Evaluation of competing diagnostic tests: sequences for the diagnosis of pulmonary embolism, Part II.

Phage-induced "one-to-many" FRET sensor for highly sensitive detection of Escherichia coli O157:H7

Transnasal Vocal Fold Augmentation

[Metapneumovirus expands the understanding of Paramyxovirus cell fusion--a review].

Bio-modification of M13 bacteriophage as signal amplification container for the highly sensitive detection of live E. Coli

Phage-based forensic tool for spatial visualization of bacterial contaminants in cheese

A Paper-Chip-Based Phage Biosensor Combined with a Smartphone Platform for the Quick and On-Site Analysis of E. coli O157:H7 in Foods

Bacteriophage‐Activated DNAzyme Hydrogels Combined with Machine Learning Enable Point‐of‐Use Colorimetric Detection of Escherichia coli

Phage-modified dual-peak long-period fiber grating biosensor for ultrasensitive, rapid and specific detection of pathogen strains

Bacteriophage-linked superparamagnetic nanoparticle for sensitive and simple detection of pathogenic Escherichia coli O157:H7 bacteria

Sensitive and Rapid Detection of Escherichia coli O157:H7 From Beef Samples Based on Recombinase Aided Amplification Assisted CRISPR/Cas12a System

EIS biosensor based on a novel Myoviridae bacteriophage SEP37 for rapid and specific detection of Salmonella in food matrixes

Synthetic phage-based approach for sensitive and specific detection of Escherichia coli O157

PCR-Based DNA Amplification and Presumptive Detection of Escherichia coli O157:H7 with an Internal Fluorogenic Probe and the 5′ Nuclease (TaqMan) Assay

In-field Detection of Multiple Pathogenic Bacteria in Food Products Using a Portable Fluorescent Biosensing System

Sensitive Detection of Escherichia coli O157:H7 Using Allosteric Probe and Hairpin Switches-Based Isothermal Transcription Amplification

Surface plasmon resonance detection of E. coli and methicillin-resistant S. aureus using bacteriophages